Kexing Biopharm Co., Ltd.

科兴生物制药股份有限公司

Develops, manufactures and commercializes biologic drugs, including recombinant proteins, antibodies and targeted-delivery therapies, focusing on oncology and autoimmune diseases, with commercialized products and pipeline candidates sold to patients worldwide.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Supplier concentration
• Overlapping customers and suppliers
• Distribution model
• Reliance on platforms, partners or licences
• Single product, business line or region
• Pricing policy and price changes
• Outsourced production (OEM / contract manufacturing)
• Overseas markets and operations
• Capacity and utilisation
• Losses and path to profitability
• Decline in revenue or profit
• Working capital: receivables, prepayments and cash cycle
• Investments and fair-value assets
• Adverse change after the track record
• Related-party transactions and balances